Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.157 NOK | -0.25% | -4.27% | -43.53% |
Sales 2023 | 354K 32.19K | Sales 2024 * | - | Capitalization | 615M 55.94M |
---|---|---|---|---|---|
Net income 2023 | -190M -17.27M | Net income 2024 * | -195M -17.73M | EV / Sales 2023 | 1,670 x |
Net cash position 2023 | 156M 14.22M | Net Debt 2024 * | 70.86M 6.44M | EV / Sales 2024 * | - |
P/E ratio 2023 |
-2.14
x | P/E ratio 2024 * |
-2.17
x | Employees | 25 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 46.59% |
Latest transcript on BerGenBio ASA
1 day | +1.52% | ||
1 week | -2.56% | ||
Current month | -17.63% | ||
1 month | -7.09% | ||
3 months | -48.45% | ||
6 months | -17.03% | ||
Current year | -42.52% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Olin
CEO | Chief Executive Officer | 55 | 21-09-07 |
Rune Skeie
DFI | Director of Finance/CFO | 51 | 18-03-04 |
Nigel McCracken
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sally Bennett
BRD | Director/Board Member | 52 | 20-12-08 |
Sveinung Hole
BRD | Director/Board Member | 57 | 10-08-31 |
Chairman | 63 | 22-01-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.157 | -0.25% | 15 718 617 |
24-04-22 | 0.1574 | -3.67% | 9,529,377 |
24-04-19 | 0.1634 | +0.99% | 12,252,360 |
24-04-18 | 0.1618 | -0.25% | 19,036,300 |
24-04-17 | 0.1622 | -1.10% | 19,221,960 |
Real-time Oslo Bors, April 23, 2024 at 06:06 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.52% | 55.77M | |
+2.49% | 96.73B | |
-0.49% | 21.31B | |
-16.61% | 21.21B | |
-5.29% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |
- Stock Market
- Equities
- BGBIO Stock